Clinical Trials Directory

Trials / Completed

CompletedNCT05296655

Kazakh Version of Reflux Symptom Index

Validity and Reliability of a Kazakh Version of Reflux Symptom Index

Status
Completed
Phase
Study type
Observational
Enrollment
248 (actual)
Sponsor
Kazakh Medical University of Continuing Education · Academic / Other
Sex
All
Age
18 Years – 74 Years
Healthy volunteers
Accepted

Summary

Reflux symptoms index (RSI) were developed to identify a clinical index of suspicion for laryngopharyngeal reflux (LPR) in patients with ear, nose, and throat symptoms. RSI is an efficient diagnostic tool for LPR/ It is easy to use, even for those who know little about LPR. It does not require special equipment or examinations and is inexpensive. Thus, it can be considered highly efficient and cost-effective. The study will focus on translating and testing the RSI into Kazakh language and comparing its results in healthy people and people with laryngopharyngeal reflux.

Conditions

Interventions

TypeNameDescription
OTHERReflux Symptom Index Inventory (diagnostic survey)Kazakh versions of the Reflux Symptom Index Inventory will be filled patients
OTHERReflux finding scorelaryngoscopy with a score RFS

Timeline

Start date
2020-03-01
Primary completion
2022-02-15
Completion
2022-02-16
First posted
2022-03-25
Last updated
2022-05-23

Locations

2 sites across 1 country: Kazakhstan

Source: ClinicalTrials.gov record NCT05296655. Inclusion in this directory is not an endorsement.